BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23028042)

  • 1. Casein kinase 1α regulates an MDMX intramolecular interaction to stimulate p53 binding.
    Wu S; Chen L; Becker A; Schonbrunn E; Chen J
    Mol Cell Biol; 2012 Dec; 32(23):4821-32. PubMed ID: 23028042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of p53-MDMX interaction by casein kinase 1 alpha.
    Chen L; Li C; Pan Y; Chen J
    Mol Cell Biol; 2005 Aug; 25(15):6509-20. PubMed ID: 16024788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDMX inhibits casein kinase 1α activity and stimulates Wnt signaling.
    Huang Q; Chen L; Schonbrunn E; Chen J
    EMBO J; 2020 Jul; 39(14):e104410. PubMed ID: 32511789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary interaction between MDMX and p53 core domain inhibits p53 DNA binding.
    Wei X; Wu S; Song T; Chen L; Gao M; Borcherds W; Daughdrill GW; Chen J
    Proc Natl Acad Sci U S A; 2016 May; 113(19):E2558-63. PubMed ID: 27114532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoinhibition of MDMX by intramolecular p53 mimicry.
    Chen L; Borcherds W; Wu S; Becker A; Schonbrunn E; Daughdrill GW; Chen J
    Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4624-9. PubMed ID: 25825738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMX acidic domain inhibits p53 DNA binding in vivo and regulates tumorigenesis.
    Huang Q; Chen L; Yang L; Xie X; Gan L; Cleveland JL; Chen J
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3368-E3377. PubMed ID: 29581299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.
    Okamoto K; Kashima K; Pereg Y; Ishida M; Yamazaki S; Nota A; Teunisse A; Migliorini D; Kitabayashi I; Marine JC; Prives C; Shiloh Y; Jochemsen AG; Taya Y
    Mol Cell Biol; 2005 Nov; 25(21):9608-20. PubMed ID: 16227609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
    Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
    EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Casein kinase 1α inhibits p53 downstream of MDM2‑mediated autophagy and apoptosis in acute myeloid leukemia.
    Xu W; Huang Z; Gan Y; Chen R; Huang Y; Xue B; Jiang S; Yu Z; Yu K; Zhang S
    Oncol Rep; 2020 Nov; 44(5):1895-1904. PubMed ID: 32901886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-derived CK1α mutations enhance MDMX inhibition of p53.
    Liu X; Huang Q; Chen L; Zhang H; Schonbrunn E; Chen J
    Oncogene; 2020 Jan; 39(1):176-186. PubMed ID: 31462704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX.
    Pazgier M; Liu M; Zou G; Yuan W; Li C; Li C; Li J; Monbo J; Zella D; Tarasov SG; Lu W
    Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4665-70. PubMed ID: 19255450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx.
    Czarna A; Popowicz GM; Pecak A; Wolf S; Dubin G; Holak TA
    Cell Cycle; 2009 Apr; 8(8):1176-84. PubMed ID: 19305137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of high affinity peptides inhibiting the interaction of p53 with MDM2 and MDMX.
    Phan J; Li Z; Kasprzak A; Li B; Sebti S; Guida W; Schönbrunn E; Chen J
    J Biol Chem; 2010 Jan; 285(3):2174-83. PubMed ID: 19910468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3.
    LeBron C; Chen L; Gilkes DM; Chen J
    EMBO J; 2006 Mar; 25(6):1196-206. PubMed ID: 16511560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of how stress-induced MDMX phosphorylation activates p53.
    Chen X; Gohain N; Zhan C; Lu WY; Pazgier M; Lu W
    Oncogene; 2016 Apr; 35(15):1919-25. PubMed ID: 26148237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for the inhibition of p53 by Mdmx.
    Popowicz GM; Czarna A; Rothweiler U; Szwagierczak A; Krajewski M; Weber L; Holak TA
    Cell Cycle; 2007 Oct; 6(19):2386-92. PubMed ID: 17938582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress-induced alternative splice forms of MDM2 and MDMX modulate the p53-pathway in distinct ways.
    Jacob AG; Singh RK; Comiskey DF; Rouhier MF; Mohammad F; Bebee TW; Chandler DS
    PLoS One; 2014; 9(8):e104444. PubMed ID: 25105592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic tethering is involved in synergistic inhibition of p53 by Mdmx and Mdm2.
    Ohtsubo C; Shiokawa D; Kodama M; Gaiddon C; Nakagama H; Jochemsen AG; Taya Y; Okamoto K
    Cancer Sci; 2009 Jul; 100(7):1291-9. PubMed ID: 19432880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting the MDM2-CK1α protein-protein interface to develop novel biologics that induce UBL-kinase-modification and inhibit cell growth.
    Huart AS; MacLaine NJ; Narayan V; Hupp TR
    PLoS One; 2012; 7(8):e43391. PubMed ID: 22916255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 Phosphomimetics Preserve Transient Secondary Structure but Reduce Binding to Mdm2 and MdmX.
    Levy R; Gregory E; Borcherds W; Daughdrill G
    Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30832340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.